Evidence map›Paper›PMID 36978343›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Occult Vancomycin-Resistant

Antonella Santona, Elisa Taviani, Maura Fiamma, Massimo Deligios, Hoa M Hoang, Silvana Sanna, Salvatore Rubino, Bianca Paglietti

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Impact of stopping contact precautions onAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  3. Deciphering vancomycin resistance inFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Antonella SantonaDepartment of Biomedical Science, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
Elisa TavianiDipartimento di Scienze della Terra, Dell'ambiente e della Vita-DISTAV-Università degli Studi di Genova, Corso Europa 26, 16132 Genova, Italy.
Maura FiammaClinical-Chemical Analysis and Microbiology Laboratory, San Francesco Hospital, 08100 Nuoro, Italy.
Massimo DeligiosDepartment of Biomedical Science, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.ORCID 0000-0002-3924-4753
Hoa M HoangDepartment of Biomedical Science, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
Silvana SannaDivision of Microbiology and Virology, University Hospital of Sassari, 07100 Sassari, Italy.
Salvatore RubinoDepartment of Biomedical Science, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
Bianca PagliettiDepartment of Biomedical Science, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
University of Sassari · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare information is available on clinical

Indexed as

cgMLSToccult vanB2-VREfmVitek2 systemWGS

Identifiers

PMID36978343
PMCPMC10044008
OpenAlexW4322500236

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read26
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.